Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Minimal Sedation After Out-of-Hospital Cardiac Arrest

Official title: Effect of Early Discontinuation of Sedation on Biomarkers of Hypoxic-Ischemic Brain Injury After Out-of-Hospital Cardiac Arrest: A Prospective Randomized Non-Inferiority Trial

Run by University Medical Centre Ljubljana · NCT07895771 · Data updated 2026-11-12

This study tests whether stopping continuous sedation right after return of circulation is as safe as keeping patients sedated in the early hours after OHCA.

More Out-Of-Hospital Cardiac Arrest trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversity Medical Centre Ljubljana
Academic / other
Locations1 site (Ljubljana)
StatusRecruiting
StartedSeptember 22, 2026
Main results expectedSeptember 2028
Study endsOctober 2028
Registry record updatedOctober 26, 2026
Trial IDNCT07895771 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who have had an OHCA with ROSC and remain comatose (FOUR motor score <4 or no verbal response).

Probably not a fit

Patients with rapid improvement, severe pre-existing neurological impairment, or conditions meeting exclusion criteria (e.g., hypothermia at randomization, high vasopressor needs) may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-centre, open-label randomized non-inferiority trial enrolling comatose adults after out-of-hospital cardiac arrest. Participants are assigned to either a minimal sedation strategy (no continuous sedation unless needed) or standard continuous sedation for at least 36 hours, with analgesia and active temperature management in both groups. The primary endpoint is serum NSE at 72 hours, with secondary outcomes including mortality, neurological status at discharge, duration of mechanical ventilation, and ICU length of stay. The study uses a web-based randomization system and follows a structured protocol for hyperthermia, shivering, seizures, and EEG monitoring over about two years. Lead site is University Medical Centre Ljubljana, Slovenia.

Why it matters

Potential benefit: If successful, the minimal sedation approach could shorten time on ventilation and ICU stay without increasing brain injury, potentially improving recovery after OHCA.

How similar studies have gone: Previous sedation strategies after OHCA show mixed results; this trial addresses a novel non-inferiority question about minimizing sedation, with prior data suggesting possible safety in carefully managed patients but not definitive.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Out-of-hospital cardiac arrest of presumed cardiac cause with return of spontaneous circulation (ROSC)
* Comatose patient (FOUR score motor response below 4, or no verbal response to pain)

Exclusion Criteria:

* Time from ROSC to randomization more than 6 hours
* Hypothermia (core body temperature 33 degrees C or lower at randomization)
* Tonic-clonic seizures at randomization
* Known severe neurological impairment before cardiac arrest (CPC 3-4)
* Extracorporeal cardiopulmonary resuscitation (E-CPR)
* Severe haemodynamic instability despite treatment: noradrenaline 0.6 micrograms/kg/min or more (or equivalent dose of another vasopressor) required to maintain MAP of 65 mmHg or more despite adequate fluid resuscitation
* Difficult ventilation: FiO2 0.8 or more or PEEP 12 cmH2O or more required to achieve SpO2 of 90% or more or PaO2 of 8.0 kPa or more, or PaCO2 above 6.5 kPa despite optimized ventilation
* Signs of raised intracranial pressure at randomization
* Proven cervical spine injury
* Pregnancy

Where it's running

  • University Medical Centre Ljubljana, Department of Intensive Internal Medicine
    Ljubljana, Slovenia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.